TY - JOUR
T1 - Sp1-mediated microRNA-182 expression regulates lung cancer progression
AU - Yang, Wen Bin
AU - Chen, Ping Hsin
AU - Hsu, Tsung I.
AU - Fu, Tzu Fun
AU - Su, Wu Chou
AU - Liaw, Hungjiun
AU - Chang, Wen Chang
AU - Hung, Jan Jong
PY - 2014
Y1 - 2014
N2 - Our recent study indicated that overexpression of Sp1 enhances the proliferation of lung cancer cells, while represses metastasis. In this study, we found that the transcriptional activity of FOXO3 was increased, but its protein levels decreased following Sp1 expression. Sp1 increased expression of miR-182, which was then recruited to the 3'-untranslated region of FOXO3 mRNA to silence its translational activity. Knockdown of miR-182 inhibited lung cancer cells growth, but enhanced the invasive and migratory abilities of these cells through increased N-cadherin expression. Repression of FOXO3 expression in the miR-182 knockdown cells partially reversed this effect, suggesting that miR-182 promotes cancer cell growth and inhibits cancer metastatic activity by regulating the expression of FOXO3. The expression of several cancer metastasis-related genes such as ADAM9, CDH9 and CD44 was increased following miR-182 knockdown. In conclusion, in the early stages of lung cancer progression, Sp1 stimulates miR-182 expression, which in turn decreases FOXO3 expression. This stimulates proliferation and tumor growth. In the late stages, Sp1 and miR-182 decline, thus increasing FOXO3 expression, which leads to lung metastasis.
AB - Our recent study indicated that overexpression of Sp1 enhances the proliferation of lung cancer cells, while represses metastasis. In this study, we found that the transcriptional activity of FOXO3 was increased, but its protein levels decreased following Sp1 expression. Sp1 increased expression of miR-182, which was then recruited to the 3'-untranslated region of FOXO3 mRNA to silence its translational activity. Knockdown of miR-182 inhibited lung cancer cells growth, but enhanced the invasive and migratory abilities of these cells through increased N-cadherin expression. Repression of FOXO3 expression in the miR-182 knockdown cells partially reversed this effect, suggesting that miR-182 promotes cancer cell growth and inhibits cancer metastatic activity by regulating the expression of FOXO3. The expression of several cancer metastasis-related genes such as ADAM9, CDH9 and CD44 was increased following miR-182 knockdown. In conclusion, in the early stages of lung cancer progression, Sp1 stimulates miR-182 expression, which in turn decreases FOXO3 expression. This stimulates proliferation and tumor growth. In the late stages, Sp1 and miR-182 decline, thus increasing FOXO3 expression, which leads to lung metastasis.
UR - http://www.scopus.com/inward/record.url?scp=84896844569&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896844569&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.1608
DO - 10.18632/oncotarget.1608
M3 - Article
C2 - 24519909
AN - SCOPUS:84896844569
SN - 1949-2553
VL - 5
SP - 740
EP - 753
JO - Oncotarget
JF - Oncotarget
IS - 3
ER -